(Q40540219)

English

Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936.

scientific article published on February 2004

In more languages
default values for all languages
No label defined

No description defined

Statements

Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit